Mortgage Marketshare Module
- Accurately track commercial and residential lending, measure sales performance against competition and market activity, identify high-performing competitors, and locate and target emerging markets.
  
  LEARN MORE >>
Loan Originator Module
- Access the largest and most comprehensive mortgage loan origination database in New England with round-the-clock interactive access and weekly trend updates.
  
  LEARN MORE >>
Marketing Lists
- Gain access to the most accurate and detailed transaction information in the country and offers a range of marketing lists for more than 130 million households (covering 94% of the U.S. population).
  
  LEARN MORE >>
Custom Research
- Powered by one-of-a-kind real estate, mortgage, and loan origination data, The Warren Group provides custom solutions for your research projects, database expansion, and strategic planning.
  
  LEARN MORE >>
Real Estate Records Search
- Access the largest and most complete real estate database in New England, including sales, price trends, liens and foreclosures.
  
  LEARN MORE >>

Cell Therapy Manufacturer Leases Space in Woburn

Jun 15, 2020 | Reprints | Print

Photo courtesy of Cummings Properties

An Israeli biotech firm that treats rare pediatric diseases is relocating from Cambridge’s Kendall Square to a Woburn facility as it prepares to begin cell therapy manufacturing.

Founded in 2012, Minovia Therapeutics develops treatments for Pearson Syndrome. The firm leased 4,600 square feet at Cummings Properties’ 12 Gill St. and will relocate this fall to the new facility containing office and lab space, Cummings Properties announced.

Minovia joins a cluster of life science firms at 12 Gill St. including ReForm Biologics, Unchained Labs and Farcast Biosciences.

Senior Leasing Director Rob Yacobian of Cummings Properties represented ownership in the lease negotiation, while Cushman & Wakefield’s Ted Lyon represented Minovia Therapeutics.

B&T Daily